Hiv infection of the central nervous system is characterized by rapid turnover of viral RNA in cerebrospinal fluid

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 3, 1999, Pages 259-264

  Eggers, Christian C ^a   Van Lunzen, Jan ^a   Buhk, Thomas ^a   Stellbrink, Hans Jürgen ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Antiretroviral therapy; Central nervous system; Cerebrospinal fluid; HIV infection; Viral kinetics

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; RNA METABOLISM; VIRUS LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032917802     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199903010-00007     Document Type: Article

References (34)

1. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
2. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
3. Stellbrink HG, van Lunzen J, Hufert FT, et al. Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph-node CD4+ T cells. AIDS 1997;11:1103-10.
4. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997;387:188-91.
5. Portegies P. HIV-1, the brain, and combination therapy [letter]. Lancet 1995;346:1244-5.
6. di Stefano M, Monno L, Fiore JR, Angarano G. In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalitis. AIDS 1997;11:133-5.
7. Gisslén M, Norkrans G, Svennerholm B, Hagberg L. The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine. J Infect Dis 1997;175:434-7.
8. Stellbrink HJ, Eggers C, van Lunzen J, Albrecht H, Greten H. Rapid decay of HIV-RNA in the cerebrospinal fluid during anti-retroviral combination therapy. AIDS 1997;11:1655-7.
9. Reiber H, Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the CNS. Clin Chim Acta 1987;163:319-28.
10. Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 1996;10:167-73.
11. de Jong MD, de Boer RJ, de Wolf F, et al. Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment. AIDS 1997;11:F79-84.
12. Stellbrink HG, Zöllner B, Fenner T, et al. Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection: evidence for an only transient interruption by treatment. AIDS 1996;10:849-57.
13. Peudenier S, Hery C, Montagnier L, Tardieu M. Human microglia cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann Neurol 1991; 29:152-61.
14. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-93.
15. Gabuzda DH, Ho DD, da la Monte SM, Hirsch MS, Rota TR, Sobel RA. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986;20:289-95.
16. Shaw GM, Harper ME, Hahn BH, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985;227:177-82.
17. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1996;39:705-11.
18. Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991;1:163-75.
19. Williams KC, Hickey WF. Traffic of hematogenous cells through the central nervous system. Curr Top Microbiol Immunol 1995; 202:221-15.
20. Petito CK, Cash KS. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992; 32:658-66.
21. Singer EJ, Syndulko K, Fahy-Chandon B, Schmid P, Conrad A, Tourtelotte WW. Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. J Acquir Immune Defic Syndr 1994;7:265-71.
22. Conrad AJ, Schmid P, Syndulko K, et al. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:425-35.
23. Ellis R, Hsia K, Spector SA, et al. Cerebrospinal fluid human immunodeficiency virus 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 1997;42:679-88.
24. Mc Arthur JC, Mc Clernon DR, Cronin MF, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997;42: 689-98.
25. Korber BT, Kunstman KJ, Patterson BK, et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994;68:7467-81.
26. Li Y, Hui H, Burgess CH, et al. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J Virol 1992;66:6587-6600.
27. Brew BJ, Evans L, Byrne C, Pemberton L, Hurren L. The relationship between AIDS dementia complex and the presence of macrophage tropic and non-syncytium inducing isolates of HIV-1 in the cerebrospinal fluid. J Neurovirol 1996;2:152-7.
28. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJS, Richman DD. In vivo compartmentalization of HIV: evidence from the examination of pol sequences from autopsy tissues. J Virol 1997;71: 2059-71.
29. Martin C, Albert J, Hansson P, Pehrsson P, Link H, Sonnerborg A. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels. J Acquir Immune Defic Syndr 1998;17:214-19.
30. Weidenheim KM, Epshteyn I, Lyman WD. Immunocytochemical identification of T-cells in HIV-1 encephalitis: implications for pathogenesis of CNS disease. Mod Pathol 1993;6:167-74.
31. Gray F, Scaravilli F, Everall I, et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996;6:1-15.
32. Price RW, Staprans S. Measuring the "viral load" in cerebrospinal fluid in HIV infection: window into brain infection? [editorial]. Ann Neurol 1997;42:675-8.
33. Iftimovici E, Rabian C, Burgard M, Peytavin G, Rouzioux C, Viard JP. Longitudinal comparison of HIV-1 RNA burden in plasma and CSF in two patients starting triple combination anti-retroviral therapy [letter]. AIDS 1998;12:535-7.
34. Pialoux G, Fournier S, Moulignier A, Poveda JD, Clavel F, Dupont B. Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir [letter]. AIDS 1997;11:1302-3.